PROCTER & GAMBLE HEALTH
|
PROCTER & GAMBLE HEALTH Last 5 Year Financial Ratios History
[Standalone]
| Jun2024 | Jun2023 | Jun2022 | Jun2021 | Jun2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 121.07 | 138.23 | 115.98 | 106.51 | 153.06 |
| CEPS(Rs) | 137.58 | 155.16 | 132.29 | 124.60 | 170.80 |
| DPS(Rs) | 260.00 | 95.00 | 52.50 | 130.00 | 230.00 |
| Book NAV/Share(Rs) | 319.10 | 447.62 | 366.99 | 421.59 | 544.82 |
| Tax Rate(%) | 26.47 | 26.97 | 24.02 | 24.21 | 28.40 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 24.30 | 24.44 | 22.73 | 24.39 | 23.18 |
| EBIT Margin(%) | 21.76 | 23.71 | 21.55 | 23.21 | 26.17 |
| Pre Tax Margin(%) | 21.71 | 23.66 | 21.51 | 23.13 | 26.17 |
| PAT Margin (%) | 15.96 | 17.28 | 16.35 | 17.53 | 18.74 |
| Cash Profit Margin (%) | 18.14 | 19.39 | 18.64 | 20.50 | 20.91 |
| Performance Ratios | |||||
| ROA(%) | 9.49 | 11.00 | 9.83 | 8.65 | 10.82 |
| ROE(%) | 31.58 | 33.94 | 29.41 | 22.04 | 20.79 |
| ROCE(%) | 42.52 | 46.07 | 38.45 | 29.08 | 29.01 |
| Asset Turnover(x) | 0.59 | 0.64 | 0.60 | 0.49 | 0.58 |
| Sales/Fixed Asset(x) | 5.18 | 5.27 | 5.17 | 4.87 | 7.04 |
| Working Capital/Sales(x) | 4.12 | 2.70 | 3.13 | 2.07 | 1.87 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.19 | 0.19 | 0.19 | 0.21 | 0.14 |
| Receivable days | 29.14 | 27.36 | 22.20 | 28.06 | 21.73 |
| Inventory Days | 35.37 | 34.37 | 36.19 | 45.68 | 33.31 |
| Payable days | 223.07 | 206.35 | 188.51 | 177.09 | 90.99 |
| Valuation Parameters | |||||
| PER(x) | 41.71 | 37.97 | 36.10 | 52.52 | 26.57 |
| PCE(x) | 36.71 | 33.83 | 31.65 | 44.89 | 23.81 |
| Price/Book(x) | 15.83 | 11.73 | 11.41 | 13.27 | 7.47 |
| Yield(%) | 5.15 | 1.81 | 1.25 | 2.32 | 5.65 |
| EV/Net Sales(x) | 7.07 | 6.73 | 5.95 | 8.74 | 4.51 |
| EV/Core EBITDA(x) | 25.30 | 24.12 | 23.59 | 33.38 | 15.91 |
| EV/EBIT(x) | 29.70 | 26.27 | 26.11 | 37.67 | 17.23 |
| EV/CE(x) | 15.12 | 11.02 | 3.42 | 4.46 | 2.89 |
| M Cap / Sales | 7.28 | 7.09 | 6.24 | 9.21 | 4.98 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -6.37 | 10.34 | 10.48 | -25.60 | 59.70 |
| Core EBITDA Growth(%) | -6.25 | 22.15 | 6.34 | -31.27 | 122.73 |
| EBIT Growth(%) | -12.99 | 24.11 | 8.42 | -34.03 | 124.62 |
| PAT Growth(%) | -12.42 | 19.19 | 8.89 | -30.42 | 149.73 |
| EPS Growth(%) | -12.42 | 19.19 | 8.89 | -30.42 | 149.73 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 1.49 | 1.72 | 1.62 | 1.89 | 2.35 |
| Quick Ratio(x) | 1.31 | 1.53 | 1.43 | 1.67 | 2.10 |
| Interest Cover(x) | 380.61 | 409.05 | 604.26 | 292.60 | - |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of PROCTER & GAMBLE HEALTH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PROCTER & GAMBLE HEALTH | ₹8,730.5 Cr | -1.2% | 5.4% | 9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
| CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,941.5 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics | |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PROCTER & GAMBLE HEALTH | -1.2% |
5.4% |
9.5% |
| SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses
